MGP
GILD icon

Metis Global Partners’s Gilead Sciences GILD Stock Holding History

Metis Global Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.44M Sell
43,024
-5,587
-11% -$736K 0.12% 125
2026
Q1 		$6.77M Sell
48,611
-5,680
-10% -$795K 0.17% 104
2025
Q4 		$6.66M Sell
54,291
-3,825
-7% -$465K 0.16% 114
2025
Q3 		$6.45M Sell
58,116
-3,151
-5% -$358K 0.15% 115
2025
Q2 		$6.79M Sell
61,267
-6,988
-10% -$744K 0.18% 99
2025
Q1 		$7.65M Buy
68,255
+7,244
+12% +$747K 0.22% 82
2024
Q4 		$5.64M Sell
61,011
-1,131
-2% -$102K 0.17% 99
2024
Q3 		$5.21M Sell
62,142
-371
-0.6% -$28.3K 0.16% 108
2024
Q2 		$4.29M Buy
62,513
+1,073
+2% +$71.6K 0.15% 115
2024
Q1 		$4.5M Buy
61,440
+1,770
+3% +$136K 0.16% 111
2023
Q4 		$4.83M Sell
59,670
-1,904
-3% -$148K 0.19% 95
2023
Q3 		$4.61M Buy
61,574
+12,545
+26% +$965K 0.22% 89
2023
Q2 		$3.78M Sell
49,029
-2,299
-4% -$183K 0.2% 101
2023
Q1 		$4.26M Buy
51,328
+7,043
+16% +$583K 0.27% 75
2022
Q4 		$3.8M Buy
44,285
+16,123
+57% +$1.28M 0.34% 62
2022
Q3 		$1.74M Sell
28,162
-808
-3% -$51K 0.28% 81
2022
Q2 		$1.79M Buy
28,970
+6,685
+30% +$414K 0.29% 79
2022
Q1 		$1.32M Buy
22,285
+8,888
+66% +$568K 0.16% 122
2021
Q4 		$973K Buy
+13,397
New +$923K 0.27% 85

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Metis Global Partners's GILD Position: Q2 2026 in Review

Metis Global Partners reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $736K and leaving 43,024 shares worth $5.44M. The position accounts for 0.12% of the portfolio, ranked #125.

Metis Global Partners first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.65M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Metis Global Partners held 43,024 shares of Gilead Sciences worth $5.44M as of Q2 2026.
  • Metis Global Partners sold 5,587 Gilead Sciences shares in Q2 2026, an estimated $736K.
  • Gilead Sciences made up 0.12% of Metis Global Partners's portfolio in Q2 2026, its #125 holding.
  • Metis Global Partners first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Gilead Sciences position peaked at $7.65M in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.